CD28-mediated co-stimulation: a quantitative support for TCR signalling.
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 6×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialThe lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“CD28-induced activation of AKT upregulates glucose metabolis”
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023 · cited 1×
“This is also indicated by studies showing that CD28 ligation lowers the number of triggered TCRs that are required for a given respons”
Background
Cited by
Items 201–300 of 797
Regulation of CD4 T cell memory by OX40 (CD134)
Salek‐Ardakani, S., & Croft, M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.108 · Cited by 71
Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses
Salerno, F., Heeren, J. J. F., Guislain, A., Nicolet, B. P., & Wolkers, M. C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801026 · Cited by 62
Regulation of T cell differentiation by the AP-1 transcription factor JunB
Katagiri, T., Kameda, H., Nakano, H., & Yamazaki, S. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1872838 · Cited by 64
Lenouvel, D., González‐Moles, M. Á., Talbaoui, A., Ramos‐García, P., González‐Ruiz, L., Ruiz‐Ávila, I., & Montoya, J. A. G. (2019) · Oral Diseases · doi:10.1111/odi.13088 · Cited by 70
Porciello, N., & Tuosto, L. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.004 · Cited by 61
Paolino, M., & Penninger, J. M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0197-9 · Cited by 66
“CD28 engagement promotes T-cell activation by enhancing TCR proximal signaling and participating in the regulation of cytokine production, cell survival, cellular metabolism, cell cycle progression, or cytoskeleton rearrangements [ 60 ].”
BackgroundSang, W., Wang, Y., Zhang, C., Zhang, D., Sun, C., Niu, M., Zhang, Z., Wei, X., Pan, B., Chen, W., et al. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.11.001 · Cited by 61
MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5
Li, W., Kong, L., Li, J., Guo, Z., Xue, Q., Yang, T., Meng, Y., Jin, B., Wen, W., & Yang, A. (2013) · International Immunology · doi:10.1093/intimm/dxt065 · Cited by 63
Co-stimulatory agonists as immunological adjuvants
Barr, T. A., Carlring, J., & HEATH, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.022 · Cited by 61
Zhang, W., Jordan, K. R., Schulte, B., & Purev, E. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s175113 · Cited by 60
“33–40 Depending on how the CAR is designed, the engineered CAR T cell takes on the immunophenotype and activation status of the costimulatory molecule with which it is engineered.”
BackgroundGenetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
Cheng, Q., Kang, Y., Yao, B. W., Dong, J., Zhu, Y., He, Y., & Ji, X. (2023) · Advanced Science · doi:10.1002/advs.202302131 · Cited by 67
Dobbins, J., Gagnon, É., Godec, J., Pyrdol, J. W., Vignali, D. A. A., Sharpe, A. H., & Wucherpfennig, K. W. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0626 · Cited by 62
Borcherding, N. C., Kolb, R. H., Gullicksrud, J. A., Vikas, P., Zhu, Y., & Zhang, W. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.030 · Cited by 69
“This interaction leads to increased PI3Kmediated proliferative signaling and cytokine production.[7, 8] A tertiary level of signaling is provided by cytokines, directing lineage specific expression of transcription factors and shaping the type of immune response.”
Chen, H., Wei, F., Yin, M., Zhao, Q., Liu, Z., Yu, B., & Huang, Z. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02838-8 · Cited by 63
Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming
Taraban, V. Y., Rowley, T. F., Tough, D. F., & Al‐Shamkhani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2969 · Cited by 61
“This therefore suggests that at least in this model the CD27 and CD28 pathways act synergistically.”
BackgroundInfluentialCD28 Superagonists: What Makes the Difference in Humans?
Schraven, B. L., & Kalinke, U. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.003 · Cited by 63
Hur, Y., Suh, C., Kim, S., & Won, J. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9057-8 · Cited by 59
Calcium dependence of T cell proliferation following focal stimulation
Schwarz, E. C., Kummerow, C., Wenning, A. S., Wagner, K., Sappok, A., Waggershauser, K., Griesemer, D., Strauß, B., Wolfs, M., Quintana, A., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737039 · Cited by 58
Innate immune receptor clustering and its role in immune regulation
Li, M., & Yu, Y. (2021) · Journal of Cell Science · doi:10.1242/jcs.249318 · Cited by 61
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
Ghaedrahmati, F., Esmaeil, N., & Abbaspour, M. (2022) · 癌症:英文版 · doi:10.1002/cac2.12394 · Cited by 62
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion
Busselaar, J., Tian, S., van Eenennaam, H., & Borst, J. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.592569 · Cited by 63
“In both CD4 and CD8 T cells, CD28 costimulation amplifies the TCR signal and drives cell division (22), while CD27 costimulation promotes cell survival and effector differentiation (3, 23–25).”
BackgroundSánchez-Valdepeñas, C., Martín, A. G., Ramakrishnan, P., Wallach, D., & Fresno, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4666 · Cited by 56
“Biological responses controlled by several extracellular stimuli may require the convergence of signaling pathways mostly at the level of the transcription factors (3).”
BackgroundNotch controls generation and function of human effector CD8+ T cells
Kuijk, L. M., Verstege, M. I., Rekers, N. V., Bruijns, S. C. M., Hooijberg, E., Roep, B. O., de Gruijl, T. D., van Kooyk, Y., & Unger, W. W. J. (2013) · Blood · doi:10.1182/blood-2012-07-442962 · Cited by 55
Miletic, A. V., Graham, D. B., Sakata-Sogawa, K., Hiroshima, M., Hamann, M. J., Cemerski, S., Kloeppel, T., Billadeau, D. D., Kanagawa, O., Tokunaga, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006599 · Cited by 54
“Of note, while previous reports indicated involvement of Vav GEF activity in CD28 signaling (reviewed in [42]), our results suggest that there may also exist a GEF-independent mechanism for Vav-mediated CD28 co-stimulation.”
ResultMembrane Rafts in T Cell Activation: A Spotlight on CD28 Costimulation
Zumerle, S., Molon, B., & Viola, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01467 · Cited by 61
Modulation of T cell function by TCR/pMHC binding kinetics
Carreño, L. J., González, P. A., & Kalergis, A. M. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.09.003 · Cited by 60
The role of CD4+ T cells in tumor and chronic viral immune responses
Xie, L., Fang, J., Yu, J., Zhang, W., He, Z., Ye, L., & Wang, H. (2023) · MedComm · doi:10.1002/mco2.390 · Cited by 61
Baruah, P., Lee, M., Odutoye, T., Williamson, P., Hyde, N. C., Kaski, J. C., & Dumitriu, I. E. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.11.005 · Cited by 56
“The survival and activation of T cells following antigen encounter depends on the balance between co-stimulatory and co-inhibitory receptors (Acuto and Michel 2003).”
Backgroundvan Bilsen, J. H. M., Sienkiewicz‐Szłapka, E., Lozano‐Ojalvo, D., Willemsen, L. E. M., Antunes, C. M., Molina, E., Smit, J. J., Wróblewska, B., Wichers, H. J., Knol, E. F., et al. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0152-0 · Cited by 53
“Stimulation of CD28 activates NF-κB signalling and the expression of GATA3, a signal favouring Th2 differentiation [103] (Fig.”
Gavali, S., Liu, J., Li, X., & Paolino, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910800 · Cited by 59
“tion threshold and essentially participates in cytokine production, cell survival, cellular metabolism, cell cycle progression, and cytoskeleton rearrangements to increase plasma fluidity and reinforce a functional immune synapse [78,79].”
BackgroundMunitić, I., Kuka, M., Allam, A., Scoville, J. P., & Ashwell, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202353 · Cited by 54
Role of Two Adaptor Molecules SLP-76 and LAT in the PI3K Signaling Pathway in Activated T Cells
Shim, E. K., Jung, S. H., & Lee, J. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001785 · Cited by 46
“subunit of PI3K, being associated with a phosphorylated YXXM motif in the cytoplasmic tail of CD28, recruits the p110 catalytic subunit, which converts PIP2 to PIP3 at the membrane (36, 52, 53).”
BackgroundToxic mechanisms of the trichothecenes T-2 toxin and deoxynivalenol on protein synthesis
Li, J., Wang, Y., Deng, Y., Wang, X., Wu, W., Nepovimová, E., Wu, Q., & Kuča, K. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113044 · Cited by 52
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
Perro, M., Tsang, J. Y., Xue, S., Escors, D., Cesco-Gaspere, M., Pospori, C., Gao, L., Hart, D. P., Collins, M. K., Stauss, H. J., et al. (2010) · Gene Therapy · doi:10.1038/gt.2010.4 · Cited by 53
Zhong, L., Zeng, G., Lü, X., Wang, R. C., Gong, G., Lin, Y., Huang, D., & Chen, Z. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005945 · Cited by 51
“Although CD28 co-stimulation has been shown to enhance TCR/CD3-mediated signaling and activation [35,36,37,38,39,40], the possibility that CD28-enhanced T-cell activation involves a stronger interaction between TCR/CD3 and CD4 co-receptor has not been tested.”
BackgroundOncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy
Zhao, X., & Subramanian, S. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.004 · Cited by 53
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Alhabbab, R. Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00312 · Cited by 53
“, 2019), while the intracellular domain of the second generation is composed of CD3ζ plus costimulatory domain such as CD28 or 4-1BB to improve CAR T cell proliferation and cytotoxic capability (Finney et al., 1998; Hombach et al., 2001; Acuto and Michel, 2003).”
BackgroundActivation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis
Zhang, Z., Zhong, W., Hinrichs, D. J., Wu, X., Weinberg, A. D., Hall, M., Spencer, D., Wegmann, K. W., & Rosenbaum, J. T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100353 · Cited by 55
“These costimulatory molecules provide a second signal that is crucial to the amplification and optimization of the T cell response.(20,21) OX40 (CD134) is a costimulatory molecule that belongs to the tumor necrosis factor receptor superfamily.”
BackgroundCo‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
Peggs, K. S., & Allison, J. P. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05627.x · Cited by 60
“…reorientation of the microtubule organising centre (MTOC), accelerated intracellular vesicular trafficking, and both general and locus-specific chromatin changes that are concomitant with nuclear localisation and the activation of transcription factors (reviewed in Acuto & Michel, 2003).”
BackgroundYang, C., Bachu, M., Du, Y., Brauner, C., Yuan, R., Kioon, M. D. A., Chesi, G., Barrat, F. J., & Ivashkiv, L. B. (2022) · Nature Communications · doi:10.1038/s41467-022-31132-7 · Cited by 55
Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy
Zhu, B., Yin, H., Zhang, D., Zhang, M., Chao, X., Scimeca, L., & Wu, M.-R. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01153-x · Cited by 62
Dietary apigenin attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice
Yano, S., Umeda, D., Yamashita, S., Yamada, K., & Tachibana, H. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.08.002 · Cited by 50
“Both the T cell receptor (TCR/CD3) and the CD28 molecule costimulation signal in T cells augment the proliferation and secretion of multiple T cell cytokines such as IL-2, IFN-γ and IL-4 [21,22].”
BackgroundMartínez-Usatorre, A., Sempere, L. F., Carmona, S. J., Carretero-Iglesia, L., Monnot, G., Speiser, D. E., Rufer, N., Donda, A., Zehn, D., Jandus, C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0504 · Cited by 52
“Therefore, PD-1 blockade prevents the inhibition of TCR and CD28 signaling that ultimately leads to the activation of NFkB and AP1 (30, 38, 39).”
BackgroundThe NOD Mouse Beyond Autoimmune Diabetes
Aubin, A., Lombard‐Vadnais, F., Collin, R., Aliesky, H. A., McLachlan, S. M., & Lesage, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874769 · Cited by 53
Seggewiss, R., Price, D. A., & Purbhoo, M. A. (2008) · Cytotherapy · doi:10.1080/14653240802317639 · Cited by 50
Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
Dai, W., Zhang, J., Li, S., He, F., Liu, Q., Gong, J., Yang, Z., Gong, Y. Q., Tang, F., Wang, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865964 · Cited by 52
“CD28 bound to B7 on APCs, and co-stimulation with TCR reduced the activation threshold of T cells, thereby promoting CD4 T cell differentiation and Th2-type cytokine expression (84).”
BackgroundPolymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses
Mandal, S., Hammink, R., Tel, J., Eksteen-Akeroyd, Z. H., Rowan, A. E., Blank, K. G., & Figdor, C. G. (2014) · ACS Chemical Biology · doi:10.1021/cb500455g · Cited by 49
Watanabe, M., Lu, Y., Breen, M., & Hodes, R. J. (2020) · Nature Communications · doi:10.1038/s41467-020-20070-x · Cited by 53
González, L., Sierra‐Cristancho, A., Cafferata, E. A., Melgar‐Rodríguez, S., Rojas, C., Carvajal, P., Cortéz, C., & Vernal, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052543 · Cited by 54
“In contrast, the alternative signaling pathway is triggered exclusively by the engagement of the TCR, which induces p38 autophosphorylation and depends on zeta chain-associated protein kinase 70 (ZAP70) [88].”
BackgroundInfluentialT cell immunotherapy enhanced by designer biomaterials
Dunn, Z. S., Mac, J., & Wang, P. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119265 · Cited by 49
“The second and third T cell stimulation signals are most commonly delivered by anti-CD28 antibodies (costimulation) and soluble IL-2 (prosurvival cytokine) [51-53].”
BackgroundApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis
Marchini, T., Hansen, S., & Wolf, D. (2021) · Cells · doi:10.3390/cells10020446 · Cited by 53
“CD4+ CTLs represent a highly differentiated subset of memory T cells [93], secrete perforin, granzyme A and B, and TNF‐α and IFN‐γ [94] and express high levels of the exhaustion marker OX‐ 40 [95].”
BackgroundPDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders
James, E. S., Harney, S. M. J., Wordsworth, B. P., Cookson, W., Davis, S. J., & Moffatt, M. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364223 · Cited by 49
Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation
Xiao, Y., Qiao, G., Tang, J., Tang, R., Guo, H., Warwar, S., Langdon, W. Y., Tao, L., & Zhang, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501200 · Cited by 47
“CD28 costimulation reduces the number of TCRs that have to be triggered for T cell activation and allows activation of T cells by low-affinity ligand (2, 3), whereas absence of CTLA-4 lowers the activation threshold (4).”
BackgroundNeisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile
Ortiz, M. C., Lefimil, C., Rodas, P. I., Vernal, R., López, M. N., Acuña‐Castillo, C., Imarai, M., & Escobar, A. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130713 · Cited by 51
“As is known, these immune responses are responsible of antibody production and induction of cytotoxic T-cell activity [41].”
BackgroundSanchez-Lockhart, M., Graf, B., & Miller, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7639 · Cited by 46
“Despite the well-known functional importance of CD28, the biochemical signaling pathways induced downstream of CD28 are not clearly understood (2, 3).”
BackgroundAging, cytomegalovirus (CMV) and influenza vaccine responses
Frasca, D., & Blomberg, B. B. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1105413 · Cited by 46
“tive activation, proliferation, and differentiation of effector function in T cells.(62) The irreversible loss of CD28 expression”
BackgroundInsulin Signaling in Arthritis
Tripolino, C., Ciaffi, J., Pucino, V., Ruscitti, P., van Leeuwen, N., Borghi, C., Giacomelli, R., Meliconi, R., & Ursini, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672519 · Cited by 46
“Stimulation of the T cell receptor (TCR) complex and ligation of the co-receptor CD28 by co-stimulatory molecules activate quiescent T cells (55).”
BackgroundSarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
The multifaceted role of PIP2 in leukocyte biology
Tuosto, L., Capuano, C., Muscolini, M., Santoni, A., & Galandrini, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2013-0 · Cited by 47
CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection
Bano, A., Pera, A., Almoukayed, A., Clarke, T. H. S., Kirmani, S., Davies, K. A., & Kern, F. (2019) · F1000Research · doi:10.12688/f1000research.17119.1 · Cited by 52
Cooperation between T cell receptor and Toll-like receptor 5 signaling for CD4 + T cell activation
Rodríguez-Jorge, O., Kempis-Calanis, L. A., Abou-Jaoudé, W., Gutiérrez‐Reyna, D. Y., Hernandez, C., Ramírez-Pliego, O., Thomas‐Chollier, M., Spicuglia, S., Santana, M. A., & Thieffry, D. (2019) · Science Signaling · doi:10.1126/scisignal.aar3641 · Cited by 47
Stochastic niche structure and diversity maintenance in the T cell repertoire
Stirk, E. R., Molina-París, C., & van den Berg, H. A. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.07.017 · Cited by 46
Transcriptional basis of lymphocyte tolerance
Borde, M., Barrington, R. A., Heissmeyer, V., Carroll, M. C., & Rao, A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00370.x · Cited by 50
“In contrast, it has been difficult to identify signals delivered independently by costimulatory receptors alone (34).”
InfluentialDennehy, K. M., Elias, F., Na, S.-Y., Fischer, K.-D., Hünig, T., & Lühder, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1363 · Cited by 45
“quantitatively amplify proximal TCR signaling (3, 9).”
Ramanathan, S., Dubois, S., Chen, X.-L., LeBlanc, C., Ohashi, P. S., & Ilangumaran, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001221 · Cited by 45
“of CD28 and influenced the expression of other costimulatory receptors GITR and 4-1BB (40, 41) occurred in cytokine-primed P14 cells.”
BackgroundImmunosuppression and Aberrant T Cell Development in the Absence of N-Myristoylation
Rampoldi, F., Bonrouhi, M., Boehm, M. E., Lehmann, W. D., Popović, Z. V., Kaden, S., Federico, G., Brunk, F., Gröne, H., & Porubský, Š. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500622 · Cited by 46
“The Lck-mediated phosphorylation of CD3 chains can be considered as a central initiator of the TCR signaling cascade (27).”
BackgroundWan, S., Ni, L., Zhao, X., Liu, X., Xu, W., Jin, W., Wang, X., & Dong, C. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.018 · Cited by 46
Modulation of immunological synapse by membrane-bound and soluble ligands
González, P. A., Carreño, L. J., Figueroa, C. A., & Kalergis, A. M. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.003 · Cited by 45
González, L., Sierra‐Cristancho, A., Rojas, C., Cafferata, E. A., Melgar‐Rodríguez, S., Cárdenas, A. M., & Vernal, R. (2021) · Aging and Disease · doi:10.14336/ad.2021.0110 · Cited by 50
“During the antigenic presentation, T lymphocytes are activated when their T-cell receptor (TCR) recognizes the antigen/MHC II complex and their CD28 receptor binds to the costimulatory molecules CD80 or CD86, expressed by antigen-presenting cells [15].”
BackgroundLe Page, A., Fortin, C., Garneau, H., Allard, N., Tsvetkova, K., Tan, C. T. Y., Larbi, A., Dupuis, G., & Fülöp, T. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-2 · Cited by 44
“However, a second signal has to be provided by occupation of costimulation molecules of activation [29-33].”
BackgroundLu, Y., Schneider, H., & Rudd, C. E. (2012) · Blood · doi:10.1182/blood-2012-04-421420 · Cited by 47
Patil, N. K., Bohannon, J. K., Luan, L., Guo, Y., Fensterheim, B. A., Hernandez, A., Wang, J., & Sherwood, E. R. (2016) · Shock · doi:10.1097/shk.0000000000000688 · Cited by 49
Neuroendocrine and viral correlates of premature immunosenescence
Bauer, M. E., Wieck, A., Petersen, L. E., & Baptista, T. S. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12786 · Cited by 44
The importance of co‐stimulation in the orchestration of T helper cell differentiation
Coquet, J. M., Rausch, L., & Borst, J. G. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.45 · Cited by 46
Betjes, M. G. H., Meijers, R. W. J., de Wit, L. E. A., & Litjens, N. H. R. (2011) · Journal of Nephrology · doi:10.5301/jn.5000057 · Cited by 46
Fisher, J. P. H., Flutter, B. R., Wesemann, F., Frosch, J., Rössig, C., Gustafsson, K. T., & Anderson, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1025194 · Cited by 43
“CD28 signaling is viewed as both qualitative (producing a specific signal via a narrowly defined pathway) and quantitative (with effect determined by signal strength).(28) Our data demonstrating the correlation of the effect (ADCC) with GD2 staining suggests that the functional effects of CD16 ligation in Vg9Vd2C gdT…”
BackgroundIpilimumab: From Preclinical Development to Future Clinical Perspectives in Melanoma
Letendre, P., Monga, V., Milhem, M. M., & Zakharia, Y. (2016) · Future Oncology · doi:10.2217/fon-2016-0385 · Cited by 47
Larbi, A., Grenier, A., Frisch, F., Douziech, N., Fortin, C. F., Carpentier, A. C., & Fülöp, T. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.949 · Cited by 44
Wu, J., Xia, L., Yao, X., Yu, X. H., Tumas, K. C., Sun, W., Cheng, Y., He, X., Peng, Y., Singh, B. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004332117 · Cited by 43
“The increased number of CD80DCs can partially explain malariainduced inhibition of immune response because CD80 can bind to CTLA4 and/or PD-L1 to dampen T cell response (50, 51, 54).”
BackgroundLes liaisons dangereuses: immunological synapse formation in animals and plants
Kwon, C., Panstruga, R., & Schulze‐Lefert, P. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.01.004 · Cited by 43
Function and evolution of the prototypic CD28ζ and 4-1BBζ chimeric antigen receptors
Feucht, J., & Sadelain, M. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.09.001 · Cited by 45
“Lack of CD28 costimulation is associated with decreased T-cell proliferation and differentiation, inhibition of germinal centre formation and repressed cytokine expression, coinciding with reduced responses to a wide spectrum of immune challenges in CD28-deficient mice.(26,30) 4-1BB (CD137) is induced transiently by T…”
BackgroundHuang, Y., Wang, Z., Zheng, Q., Tang, J., Cai, J. X., Lu, Y., & Jian, J. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.10.008 · Cited by 43
“On-CD80/86 contains a vital extracellular Ig domain that is responsible for the binding of On-CD80/86 to their receptors, such as CD28 and CTLA-4, and plays an important role in T cell activation in mammals [32,33].”
BackgroundCutting Edge: Requirement for TRAF6 in the Induction of T Cell Anergy
King, C. G., Buckler, J. L., Kobayashi, T., Hannah, J., Bassett, G., Kim, T. S., Pearce, E. L., Kim, G. G., Turka, L. A., & Choi, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.34 · Cited by 41
“Thus, it is possible that decreased Cbl-b expression in TRAF6- T T cells is responsible for the hyperactivation of PI3K/Akt, which in turn renders TRAF6- T T cells resistant to anergy induction.”
BackgroundInfluentialCAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects
Choudhery, M. S., Arif, T., Mahmood, R., & Harris, D. T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113202 · Cited by 42
“They employed two distinct constructs: one that had only the co-stimulatory domain CD28 and the other that contained both CD28 and 4-1BB.”
The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies
Zhao, L., Wang, Q., Zhou, B., Zhang, L., & Zhu, H. (2021) · Aging and Disease · doi:10.14336/ad.2020.0410 · Cited by 41
“Naïve T cells express CD28 as a costimulatory molecule for antigen‐driven activation and proliferation [36, 37].”
BackgroundThe Role of O-GlcNAcylation in Immune Cell Activation
Qiang, A., Slawson, C. M., & Fields, P. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.596617 · Cited by 43
“Antigen-presenting cells (APC) with major histocompatibility complex II (MHC II) present antigenic peptides on its surface to activate naive T cells if the T cell receptor recognizes the antigen, and if a second signal from a costimulatory molecule like CD28 is also present (1, 2).”
BackgroundErtl, H. C. J. (2023) · Drugs · doi:10.1007/s40265-023-01836-1 · Cited by 43
“This signaling is enhanced by CD28 ligation [45], which upon PI3K activation also stimulates the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway that through hypoxia-inducible factor 1-alpha (HIF1a) changes the T cells’ metabolism towards glycolysis to allow for rapid proliferation [46].”
BackgroundSulzgruber, P., Koller, L., Winter, M., Richter, B., Blum, S., Korpak, M., Hülsmann, M., Goliasch, G., Wojta, J., & Niessner, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-07-0531 · Cited by 43
“CD28+ represents a co-stimulatory receptor on CD4+ cells, which is pivotal for the regulation in cell activation, proliferation and survival (7).”
BackgroundMolecular Insights for Optimizing T Cell Receptor Specificity Against Cancer
Hebeisen, M., Oberle, S. G., Presotto, D., Speiser, D. E., Zehn, D., & Rufer, N. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00154 · Cited by 45
“Members of the tumor necrosis factor receptor (TNFR) superfamily represent further important co-stimulatory molecules, mediating survival signals to T cells after initial CD28-B7 interactions (Acuto and Michel, 2003) (Figure 2).”
BackgroundA Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
Importance of Feedback and Feedforward Loops to Adaptive Immune Response Modeling
Rahman, A., Tiwari, A., Narula, J., & Hickling, T. P. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12352 · Cited by 43
“As an APC, B cells bind antigens to its surface expressed immunoglobulin (B- cell receptors), internalizes antigen, processes antigen by internal machinery, binds antigenic peptides to MHC- II molecules, and present them on the cell surface like DCs.85–87 In the T- cell dependent mechanism, binding of antigen is not s…”
BackgroundInfluentialTracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer
Wierstra, P. J., Sandker, G. W., Aarntzen, E. H. J. G., Gotthardt, M., Adema, G. J., Bussink, J., Raavé, R., & Heskamp, S. (2019) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-019-0078-z · Cited by 39
Lith, S. C., van Os, B. W., Seijkens, T. T. P., & de Vries, C. J. M. (2020) · European Journal of Immunology · doi:10.1002/eji.202048869 · Cited by 42
NOD1 Cooperates with TLR2 to Enhance T Cell Receptor-Mediated Activation in CD8 T Cells
Mercier, B. C., Ventre, E., Fogeron, M., Mathieu, A., Tomkowiak, M., Marvel, J., & Bonnefoy, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042170 · Cited by 40
“C) Flow cytometry assessment of the proliferation (the percentage of proliferating cells is indicated within the histograms) (A), cell numbers (B) and CD25 expression (the mean fluorescence intensity of CD8 T cells is indicated within the histograms) (C) of CFSE stained murine CD8 T cells cultured for 48 h with anti-C…”
BackgroundInfluentialVaccines for Pancreatic Cancer
Soares, K. C., Zheng, L., Edil, B. H., & Jaffee, E. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182756903 · Cited by 43
TCR and CD28 Concomitant Stimulation Elicits a Distinctive Calcium Response in Naive T Cells
Xia, F., Qian, C., Xun, Z., Hamon, Y., Sartre, A.-M., Formisano, A., Mailfert, S., Phélipot, M.-C., Billaudeau, C., Jaeger, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02864 · Cited by 39
“It is therefore considered that CD28 contributes both quantitatively and qualitatively to the signaling pathways driving T cell activation (2).”
BackgroundResultInfluentialSite-specific regulation of Th2 differentiation within lymph node microenvironments
Lyons‐Cohen, M. R., Shamskhou, E. A., & Gerner, M. Y. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231282 · Cited by 41
Adipose tissue in older individuals: a contributing factor to sarcopenia
Wang, T., Zhou, D., & Hong, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155998 · Cited by 40
Phosphatidylinositol 4-Phosphate 5-Kinases in the Regulation of T Cell Activation
Porciello, N., Kunkl, M., Viola, A., & Tuosto, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00186 · Cited by 38
Zhang, J., Larrocha, P. S.-L., Zhang, B., Wainwright, D. A., Dhar, P., & Wu, J. D. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0693-y · Cited by 38
Metadata
- Authors
- Acuto, O., & Michel, F.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Acuto, Oreste
- ORCID
- Michel, Frédérique
- Venue
- Nature Reviews Immunology
- Published
- 2003-12
- Volume
- 3
- Issue
- 12
- Pages
- 939-951
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2055248228
- Cited by
- 775
- References
- 157
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 31 · 2023: 23 · 2022: 42 · 2021: 33 · 2020: 32 · 2019: 25 · 2018: 38 · 2017: 43 · 2016: 42 · 2015: 35 · 2014: 29 · 2013: 37 · 2012: 33
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, costimulation, T cell receptor signaling, T cell activation, naive T cells, clonal expansion, costimulatory receptors, signal amplification
- MeSH terms
- Animals, Carrier Proteins, Cell Cycle, Humans, Lymphocyte Activation, Membrane Proteins, Phosphoproteins, T-Lymphocytes, Signal Transduction, CD28 Antigens, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.